| abstract |
Compositions are provided comprising a therapeutically effective amount of a multikinase inhibitor, such as nintedanib or axitinib or pazopanib, wherein the composition optionally comprises a surfactant (eg polysorbate 80) as a solubilizer, optionally Cyclic oligosaccharides such as cyclodextrin (eg, 2-hydroxypropyl-beta-cyclodextrin) with a lipophilic carrier (eg, castor oil), polyoxyl oil (eg, polyoxyl-35 castor) free) emulsions, such as nanoemulsions. Methods of treating an ophthalmic condition using the composition are also provided. |